Drawing for SELPH

USPTO serial 99895176

SELPH

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SHEEHY, CONNOR RYAN
Law office
TMO LAW OFFICE 138

What this means

Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.

Status 680: Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose.

Need help with SELPH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles Aini

1178 Broadway 5th FloorNew York, NY 10001United States

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated skin care preparations, namely, creams, lotions, gels, serums, cleansers, masks, body wash, body lotion, hand cream, face and body lotions, facial lotion, facial moisturizers, skin conditioners, skin moisturizers, lip balm, and non-medicated nipple cream and diaper rash cream; Non-medicated toiletry preparations; Antiperspirants and deodorants for personal use; Body sprays; Make-up remover; Patches containing non-medicated skin care preparations; Sunscreen preparations; Non-medicated mouthwashes; Tooth paste; Room fragrances; Non-medicated bar soap; Non-medicated bath soaps in liquid, solid or gel form; Hair conditioners for babies; Shampoos for babies; Baby lotion; Baby oil; Baby wipes impregnated with cleaning preparations; Foot deodorant spray; Non-medicated foot lotions; Non-medicated foot cream; Non-medicated foot powder; Non-medicated nail care preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 28, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 28, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 28, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 28, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 28, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 28, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 28, 2026DOCKASSIGNED TO EXAMINER—
Oct 26, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 19, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 19, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance